본문 바로가기

Synergistic impact of autocrine motility factor and curcumin on colorectal cancer cell proliferation

문서 유형
연구출판물 · 학술지 논문
등재
KCISCIEScopus
저널 순위
JCR Q2Scopus Q2KCI Q4
저널
Applied Biological Chemistry66(1) · #90 · 2023
피인용
Web of Science 9Scopus 8KCI 0
FWCI (Scopus)
2.2
JCR IF
JCR 2022 3.2
ISSN
2468-0834

저자

  1. Kim, Seok Joong제1저자Dongduk Womens Univ, Coll Nat & Informat Sci, Dept Food & Nutr, Seoul 02758, South Korea
  2. Kim, YangjiDongduk Womens Univ, Coll Nat & Informat Sci, Dept Food & Nutr, Seoul 02758, South Korea
  3. 즈엉반탄Pusan Natl Univ, Sch Med, Dept Anat, Yangsan 50612, South Korea
  4. Park, Hee Sung교신저자Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Jinju 52828, South Korea

초록

Colorectal cancer (CRC) presents a formidable challenge, characterized by a steadily increasing incidence. Current approaches to manage CRC, including chemotherapy and targeted therapies, are burdened with significant limitations such as resistance development, adverse events, and high costs. Hence, there is an urgent demand for a more promising alternative. Autocrine motility factor (AMF), known for its role in promoting cancer cell motility, exhibits a unique ability to selectively impede the growth of cancer cells. In our study, we have elucidated the specific inhibitory effect of AMF derived from DU145 prostate cancer cells (D-AMF) on the proliferation of CRC cells. D-AMF effectively downregulated the expression of glucose-6-phosphate dehydrogenase (G6PD) at both the mRNA and protein levels, resulting in a concurrent increase in the generation of reactive oxygen species (ROS). Notably, the combination of D-AMF and curcumin proved highly effective in eliminating curcumin-resistant CRC cells. Therefore, the use of D-AMF in conjunction with curcumin holds promise as an alternative treatment approach for CRC.

키워드

Autocrine motility factorColorectal cancer cellsCurcuminGlucose-6-phosphate dehydrogenaseReactive oxygen species

식별자

Scopus EID
2-s2.0-85179920085
WoS UID
001123971400001
KCI
ART003024127